Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy.
J Neuroendocrinol. 2011 Jul;23(7):591-600. doi: 10.1111/j.1365-2826.2011.02152.x.
Palmitoylethanolamide (PEA) regulates many pathophysiological processes in the central nervous system, including pain perception, convulsions and neurotoxicity, and increasing evidence points to its neuroprotective action. In the present study, we report that PEA, acting as a ligand of peroxisome-proliferator activated receptor (PPAR)-α, might regulate neurosteroidogenesis in astrocytes, which, similar to other glial cells and neurones, have the enzymatic machinery for neurosteroid de novo synthesis. Accordingly, we used the C6 glioma cell line and primary murine astrocytes. In the mitochondrial fraction from cells stimulated with PEA, we demonstrated an increase in steroidogenic acute regulatory protein (StAR) and cytochrome P450 enzyme (P450scc) expression, both comprising proteins considered to be involved in crucial steps of neurosteroid formation. The effects of PEA were completely blunted by GW6471, a selective PPAR-α antagonist, or by PPAR-α silencing by RNA interference. Accordingly, allopregnanolone (ALLO) levels were increased in supernatant of PEA-treated astrocytes, as revealed by gas chromatography-mass spectrometry, and this effect was inhibited by GW6471. Moreover, PEA showed a protective effect, reducing malondialdehyde formation in cells treated with l-buthionine-(S,R)-sulfoximine, a glutathione depletor and, interestingly, the effect of PEA was partially inhibited by finasteride, a 5α-reductase inhibitor. A similar profile of activity was demonstrated by ALLO and the lack of an additive effect with PEA suggests that the reduction of oxidative stress by PEA is mediated through ALLO synthesis. The present study provides evidence indicating the involvement of the saturated acylethanolamide PEA in ALLO synthesis through PPAR-α in astrocytes and explores the antioxidative activity of this molecule, confirming its homeostatic and protective role both under physiological and pathological conditions.
棕榈酰乙醇酰胺(PEA)调节中枢神经系统中的许多病理生理过程,包括疼痛感知、惊厥和神经毒性,越来越多的证据表明其具有神经保护作用。在本研究中,我们报告 PEA 作为过氧化物酶体增殖物激活受体(PPAR)-α的配体,可能调节星形胶质细胞中的神经甾体生成,类似于其他神经胶质细胞和神经元,星形胶质细胞具有从头合成神经甾体的酶机制。因此,我们使用 C6 神经胶质瘤细胞系和原代小鼠星形胶质细胞。在细胞用 PEA 刺激后的线粒体部分,我们证明了甾体生成急性调节蛋白(StAR)和细胞色素 P450 酶(P450scc)表达增加,这两种蛋白都被认为参与神经甾体形成的关键步骤。PPAR-α拮抗剂 GW6471 或 RNA 干扰沉默 PPAR-α 完全阻断了 PEA 的作用。因此,通过气相色谱-质谱分析,在 PEA 处理的星形胶质细胞上清液中发现 ALLO 水平增加,而 GW6471 抑制了这一作用。此外,PEA 显示出保护作用,降低了 L-丁硫氨酸-(S,R)-亚砜亚胺处理的细胞中丙二醛的形成,有趣的是,PEA 的作用部分被 5α-还原酶抑制剂非那雄胺抑制。ALLO 表现出类似的活性谱,PEA 缺乏与 ALLO 的附加作用表明 PEA 通过 ALLO 合成减轻氧化应激。本研究提供的证据表明,饱和酰基乙醇酰胺 PEA 通过星形胶质细胞中的 PPAR-α 参与 ALLO 合成,并探索了该分子的抗氧化活性,证实了其在生理和病理条件下的稳态和保护作用。